Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Lesokhin
CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
The Current Status of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Hematopoietic Stem Cell Transplantation for Multiple Myeloma Beyond 2010
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Patients With Multiple Myeloma Develop SOX2-Specific Autoantibodies After Allogeneic Stem Cell Transplantation
Clinical and Developmental Immunology
Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
Seminars in Hematology
Hematology
Allogeneic Hematopoietic Stem Cell Transplantation
Archives of Internal Medicine
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes Between CD34 + Selected or Unmodified Hematopoietic Stem Cells Transplants
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD34+-Selected Stem Cell Boost Without Further Conditioning for Poor Graft Function After Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Lenalidomide Induced Graft-Versus-Host Disease in a Patient With Relapsed Multiple Myeloma Three and a Half Years After Allogeneic Hematopoietic Stem Cell Transplantation
Journal of Hematopoietic Cell Transplantation